Abstract
Hepatitis B virus (HBV) infection is recognised as an important cause of nephrotic syndrome in endemic areas. This paper retrospectively examines the natural history and treatment of 70 patients with membranous glomerulonephritis and 1 with mesangiocapillary glomerulonephritis associated with HBV infection. Thirty-seven patients were in complete remission by the end of the study. The average duration of proteinuria in these patients was 30 months. The cumulative probability of remission was 64% at 4 years and 84% at 10 years. Three patients were still nephrotic after more than 90 months of follow-up and 2 others had reached end-stage renal failure. Remission occurred within 6 months of clearing the e antigen (HBeAg) in the majority of cases. Steroids alone were given to 10 patients and 2 received steroids and cyclophosphamide, with no beneficial effect. Three patients received interferon-α 2b. One cleared the HBeAg from the circulation and had a significant fall in proteinuria, but defaulted from follow-up a month after completing treatment. One had a reduction of proteinuria but remained HBeAg positive. There was no change in the condition of the third. Although the majority of children eventually enter remission, there is a significant morbidity associated with the disease. Steroids and other immunosuppressive therapy are of no benefit. Interferon therapy may be useful, but has not been adequately assessed.
Similar content being viewed by others
References
Report of the Second Task Force on Blood Pressure Control in Children (1987) Pediatrics 78: 1–25
Counahan R, Chantler C, Ghazali S, Kirkwood B, Rose F, Barratt TM (1976) Estimation of glomerular filtration rate from the plasma creatinine in children. Arch Dis Child 51:875–878
Kleinknecht C, Levy M, Peix A, Broyer M, Courtecuisse V (1979) Membranous glomerulonephritis and hepatitis B surface antigenaemia in children. J Pediatr 95:946–952
Wiggelinkhuizen J, Sinclair-Smith C, Stannard LM, Smuts H (1983) Hepatitis B virus associated membranous glomerulonephritis. Arch Dis Child 58:488–496
Hsu H-C, Wu C-Y, Lin C-Y, Lin G-J, Chen C-H, Huang F-U (1989) Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney Int 36:1103–1107
Lin C-Y (1990) Hepatitis B virus associated membranous nephropathy: clinical features, immunological profiles and outcome. Nephron 55:37–44
Seggie J, Nathoo K, Davies PG (1984) Association of hepatitis B (HBs) antigenaemia and membranous glomerulonephritis in Zimbabwean children. Nephron 38:115–119
Johnson RJ, Couser WG (1990) Hepatitis B infection and renal disease: clinical immunologic and therapeutic considerations. Kidney Int 37:663–676
Lai KN, Lai FM-M, Chan KW, Chow CB, Tong KL, Vallence-Owen J (1987) The clinico-pathological features of hepatitis B virus-associated glomerulonephritis. Q J Med 63:323–333
Venkataseshan VS, Lieberman K, Kim DU, Thung SN, Dikman S, D'Agati V, Susin M, Valdreama E, Gauthier B, Prakash A, Churg J (1990) Hepatitis B-associated glomerulonephritis: pathology, pathogenesis and clinical course. Medicine (Baltimore) 69:200–216
Elidressey ATH, Abdurrahman MB, Raima S, Lynch JB (1988) Hepatitis B surface antigen associated nephrotic syndrome. Ann Trop Paediatr 8:157–161
Lai KN, Li PKT, Lui SF, Au TC, Tam JSL, Tong KL, Lai FM-M (1991) Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324:1457–1463
Southwest Pediatric Nephrology Study Group (1985) Hepatitis B surface antigenaemia in North American children with membranous glomerulonephropathy. J Pediatr 106:571–578
Lisker-Melman M, Webb D, Di Bisceglie AM, Kassianides C, Martin P, Rustgi V, Waggoner JG, Park Y, Hoofnagle JH (1989) Glomerulonephritis caused by hepatitis B virus infection: treatment with recombinant human alpha-interferon. Ann Intern Med 111:479–483
Garcia G, Scullard G, Smith C, Weissberg J, Alexander S, Robinson WS, Gregory P, Merigan TC (1985) Preliminary observation of hepatitis B-associated membranous glomerulonephritis treated with leukocyte interferon. Hepatology 5:317–320
Mizushima N, Kanai K, Matsuda H, Matsumoto M, Tamakoshi K, Ishii H, Nakajima T, Yoshimi T, Kimura M, Nagase M (1987) Improvement of proteinuria in a case of hepatitis B-associated glomerulonephritis after treatment with interferon. Gastroenterology 92:524–526
De Man RA, Schalm SW, Van der Heijden AJ, Ten Kate FWJ, Wolff ED, Heijtink RA (1989) Improvement of hepatitis B-associated glomerulonephritis after anti-viral combination therapy. J Hepatol 8:367–372
Wong S-N, Yu ECL, Lok ASF, Chan K-W, Lau Y-L (1992) Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children. Pediatr Nephrol 6:417–420
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gilbert, R.D., Wiggelinkhuizen, J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol 8, 11–14 (1994). https://doi.org/10.1007/BF00868249
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00868249